https://www.moneycontrol.com/news/business/stocks/biocon-3-lower-despite-2x-rise-in-q2-net-profit-11730641.html
0
0
11/13/23 at 4:18am
Organization
Moneycontrol
Author
Moneycontrol News
34 words
0
Comments
Analysts at Motilal Oswal have reiterated their neutral call with a target price of Rs 220 as the financial results missed their estimates.
You are the first to view
Create an account
or login to join the discussion